• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Ask AI
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.de
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Ask AI
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Press

VASRO GmbH > Press

Luberef Reports Record H1 2026 Earnings as Base Oil Margins Drive Cash Flow and Higher Valuation

  • August 5, 2026
  • Equity Research Coverage
VASRO has published an updated equity research report on Saudi Aramco Base Oil Company – Luberef, maintaining its BUY recommendation and raising the target price from SAR 136.00 to...
Continue Reading

Ainos, Inc.: AI Nose Starts Reading the Breath Itself in New Emergency-Medicine Study at National Taiwan University

  • June 22, 2026
  • Equity Research Coverage
VASRO has published an update report on Ainos, Inc. following the company’s announcement of a one-year research program with National Taiwan University. The report, titled “AI Nose Starts Reading...
Continue Reading

Ainos, Inc.: AI Nose Enters Live Hospital Emergency-Room Deployment at NTUH

  • June 5, 2026
  • Equity Research Coverage
VASRO has published an update report on Ainos, Inc. following the company’s announcement of an IRB-approved research program with National Taiwan University Hospital. The report, titled “AI Nose Enters...
Continue Reading

Saudi Aramco Base Oil Company – Luberef: Q1 Confirms Earnings Resilience and Growth II Progress — VASRO Reiterates BUY

  • May 25, 2026
  • Equity Research Coverage
VASRO has published an update report on Saudi Aramco Base Oil Company – Luberef following the company’s Q1 2026 results. The core investment message is unchanged: Luberef remains a...
Continue Reading

Ainos, Inc.: AI Nose Builds Broader Operating Footprint Across Semiconductors and Healthcare

  • May 19, 2026
  • Equity Research Coverage
The report, titled “AI Nose Builds a Broader Operating Footprint Across Semiconductors and Healthcare,” reviews Ainos’ Q1 2026 progress and frames the quarter as a build-out phase for the...
Continue Reading

Spinneys 1961 Holding PLC: Demand Quality Holds Despite March Logistics Shock – VASRO Reiterates BUY

  • May 14, 2026
  • Equity Research Coverage
VASRO has published an update report on Spinneys 1961 Holding PLC following the company’s Q1 2026 results. The core investment message is unchanged: demand quality remains strong, the operating...
Continue Reading

Ainos Inc.: AI Nose Deployment in Hospital Infrastructure Marks Transition to Scalable Multi-Domain Platform

  • April 16, 2026
  • Equity Research Coverage
VASRO’s latest update on Ainos Inc. focuses on a new operational milestone that materially strengthens the company’s platform thesis. Through a partnership with MacKay Memorial Hospital and Topco Scientific,...
Continue Reading

Saudi Aramco Base Oil Company – Luberef Initial Report

  • April 7, 2026
  • Equity Research Coverage
initiated. In VASRO’s initial equity report, Luberef is framed as a focused base oils platform rather than a generic energy exposure. The core point is straightforward: even through a...
Continue Reading

Spinneys Update — Core Operations Intact; Regional Volatility Not Yet Showing an Operating Break

  • April 1, 2026
  • Equity Research Coverage, Unkategorisiert
tracked. This update is not arguing that the regional backdrop is easy; it is arguing that Spinneys’ operating story has not visibly broken. Since the FY2025 release, the company’s...
Continue Reading

Ainos Update — FY2025 and the 10-K Add Structure to 2026 AI Nose Execution

  • April 1, 2026
  • Equity Research Coverage
tracked. This update does not introduce a new thesis; it gives the existing one more structure. FY2025 revenue rose to USD 124,157, gross profit turned positive at USD 102,911,...
Continue Reading

Posts pagination

Previous 1 2 3 … 37 Next

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Sirnaomics Ltd.: The RNAimmune Money Is In, and the FDA Has Answered in Writing on STP705 October 12, 2026
Ainos, Inc.: A Partner Pays for VELDONA, and Ainos Keeps the Platform September 29, 2026
Ainos Inc: A Front-End Customer Starts Ordering, and the Dataset Passes a Billion September 16, 2026
Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • info@vasro.de
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.